The Menopause Management Vacuum. Issue 3 (May 2022)

• Record Type: Journal Article
• Authors: Faubion, Stephanie S.; Shufelt, Chrisandra
• Is Part Of: Cancer journal. Volume 28:Issue 3(2022)
• Page Start: 191
• Page End: 195
• Publication Date: 2022-05
• Subjects: Compounded hormone therapy -- Femtech -- menopause -- menopause education -- menopause treatment; Cancer -- Periodicals; 616.994005
• DOI: 10.1097/PPO.0000000000000594
• Languages: English
• ISSNs: 1528-9117

Abstract

Abstract: The burden of untreated menopause symptoms in midlife women is substantial and can result in reduced quality of life as well as lost work productivity, lost opportunities for advancement at work, and increased health care costs. Unfortunately, the health care system is largely unprepared to help women manage these symptoms, which have a mean duration of 7 to 9 years. Hormone therapy usage rates have plummeted following publication of the results of the Women's Health Initiative trials due to safety concerns. In addition, postgraduate medical training programs include minimal to no training on menopause management. These and other factors have contributed to what is essentially a menopause management vacuum. This vacuum created a market opportunity, particularly given the fact that midlife women are potent drivers of the global economy. In this review, we outline the menopause management gaps and discuss a multipronged approach to close these gaps and improve the care of midlife women.